KEBILIDI is an adeno-associated virus vector-based gene therapy indicated for the treatment ... KEBILIDI is contraindicated in patients who have not achieved skull maturity assessed by neuroimaging.

This is the first gene therapy for AADC deficiency to receive US regulatory approval and the first that can be administered directly to the brain.

A new high-resolution neural recording method developed by Johns Hopkins APL and the School of Medicine detects neural ...

When I started my research on the Samuel George Morton Cranial Collection, a librarian leaned over my laptop one day to share ...

The fossil, discovered in Brazil, is remarkably well-preserved, allowing researchers to digitally reconstruct the bird's ...

Early humans may have reached adulthood around the same age as great apes, but with a slower, human-like pattern of tooth ...